🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the manufacturers of Tylenol, asserting the firms hid safety concerns that the drug posed to pediatric cognitive development.

The lawsuit follows a month after President Donald Trump advocated an unproven link between taking acetaminophen - referred to as paracetamol - while pregnant and autism in children.

The attorney general is suing J&J, which once produced the medication, the exclusive pain medication recommended for women during pregnancy, and the current manufacturer, which now manufacturers it.

In a declaration, he claimed they "deceived the public by making money from suffering and pushing pills regardless of the risks."

Kenvue states there is lacking scientific proof linking Tylenol to autism.

"These manufacturers lied for decades, intentionally threatening millions to line their pockets," the attorney general, from the Republican party, stated.

The manufacturer stated officially that it was "very worried by the dissemination of inaccurate information on the safety of paracetamol and the likely effects that could have on the health of women and children in America."

On its official site, the company also stated it had "continuously evaluated the applicable studies and there is lacking reliable evidence that demonstrates a verified association between using acetaminophen and autism."

Organizations representing medical professionals and healthcare providers concur.

The American College of Obstetricians and Gynecologists has declared acetaminophen - the main ingredient in acetaminophen - is among limited choices for expectant mothers to address discomfort and fever, which can pose major wellness concerns if left untreated.

"In multiple decades of studies on the use of acetaminophen in pregnancy, zero credible investigations has definitively established that the usage of paracetamol in any stage of pregnancy leads to neurodevelopmental disorders in offspring," the organization commented.

The lawsuit mentions latest statements from the Trump administration in claiming the medication is reportedly hazardous.

Recently, the former president generated worry from public health officials when he instructed women during pregnancy to "struggle intensely" not to take Tylenol when unwell.

The FDA then released a statement that doctors should consider limiting the consumption of Tylenol, while also mentioning that "a causal relationship" between the drug and autism spectrum disorder in minors has remains unverified.

The Health Department head RFK Jr, who oversees the Food and Drug Administration, had vowed in April to conduct "extensive scientific investigation" that would identify the cause of autism in a short period.

But authorities warned that discovering a sole reason of autism - thought by researchers to be the result of a complicated interplay of genetic and environmental factors - would not be simple.

Autism spectrum disorder is a type of permanent neurological difference and disability that impacts how individuals encounter and relate to the environment, and is diagnosed using physician assessments.

In his legal document, Paxton - a Trump ally who is running for US Senate - alleges Kenvue and J&J "deliberately disregarded and tried to quiet the science" around paracetamol and autism spectrum disorder.

The case aims to force the firms "eliminate any promotional materials" that states Tylenol is reliable for women during pregnancy.

The court case parallels the grievances of a assembly of parents of minors with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the makers of Tylenol in two years ago.

The court threw out the legal action, stating investigations from the plaintiffs' authorities was not conclusive.